Lifshitz, PC Law Firm Announces Ardelyx Investigations

0

NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) —

Ardelyx Inc. (NASDAQGM: ARDX)

Lifshitz Law PLLC announces that a class action lawsuit has been filed on behalf of ARDX stockholders alleging that defendants have made materially false and misleading statements regarding tenapanor and the likelihood of it being approved by the FDA during the period of recourse, which led investors to suffer significant damages. losses.

If you are an ARDX investor and would like additional information about our investigation, please complete the information request form or contact Joshua Lifshitz, Esq. by phone at (516)493-9780 or by email at [email protected]

Hyzon Motors Inc. (NASDAQ: HYZN)

Lifshitz Law PLLC announces that a class action complaint has been filed against Hyzon alleging that the defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Hyzon distorted the nature of its “customer” contracts and severely embellished its “deals” and “partnerships” with customers; (2) Hyzon was unable to deliver its announced vehicles in 2021, within the announced timeframe; and (3) as a result, the defendants’ public statements were materially false and/or misleading at all relevant times.

If you are a Hyzon investor and would like additional information about our investigation, please complete the information request form or contact Joshua Lifshitz, Esq. by phone at (516)493-9780 or by email at [email protected]

View, Inc. (NASDAQGM: VIEW)

Lifshitz Law PLLC announces that a class action lawsuit has been filed against View alleging that the defendants failed to disclose to investors: (1) that View improperly accounted for warranty fees related to its product; (2) that there was a material weakness in View’s internal controls over accounting and financial reporting related to collateral accrual; (3) that, as a result, the Company’s financial results for prior periods were incorrect; and (4) as a result, defendants’ statements regarding its business, operations and prospects were materially false and misleading and/or lacked reasonable basis at all relevant times.

If you are a View investor and would like additional information about our investigation, please complete the information request form or contact Joshua Lifshitz, Esq. by phone at (516)493-9780 or by email at [email protected]

Zymergen Inc. (NASDAQGS: ZY)

Lifshitz Law PLLC announces that a class action lawsuit has been filed against Zymergen alleging that the defendants failed to disclose to investors: (1) that during the qualification process for Hyaline, key customers experienced technical issues, including product reduction and incompatibility with customers. process ; (2) that while the qualification process was critical to gaining market acceptance of Hyaline and generating revenue, Zymergen lacked visibility into the qualification process; (3) that, as a result, the Company overestimated the demand for its products; (4) that as a result of the foregoing, the Company’s product delivery schedule was reasonably likely to be delayed, which in turn would delay revenue generation; and (5) that as a result of the foregoing, defendants’ positive statements about the company’s business, operations and prospects were materially misleading and/or lacked reasonable basis.

If you are a Zymergen investor and would like additional information about our investigation, please complete the information request form or contact Joshua Lifshitz, Esq. by phone at (516)493-9780 or by email at [email protected]

LAWYER ADVERTISING.© 2022 Lifshitz Law LLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, tel. : (516) 493-9780. Past results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz Law SARL
Telephone: 516-493-9780
Fax: 516-280-7376
E-mail: [email protected]

Share.

Comments are closed.